Displaying items 25-36 of 151
» View wsbt.com items only
< Previous
1
2
3
4
5
6
7
8
9
10
11-13
Next >
-
Big drugmakers think small with nanomedicine deals
Reuters* Nanomedicine promises greater precision and monitoring * Pfizer, Amgen, AstraZeneca among firms placing bets * Early-stage research but scientists see momentum building By Ben Hirschler LONDON, May 3 (Reuters) - Is nanomedicine the next big thing? A...Tags: Chemical Industry, Colleges and Universities, AIDS, Massachusetts Institute of Technology, Biotechnology Industry
-
Deals of the day -- mergers and acquisitions
ReutersMay 2 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** New York-based private equity firm Lightyear Capital has emerged as the lead bidder to buy SunTrust Banks Inc's RidgeWorth Investments...Tags: Companies and Corporations, Mergers, Acquisitions and Takeovers, Politics, France Telecom, Norway
-
PRESS DIGEST-New York Times business news - May 10
ReutersMay 10 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. * The Bank of Japan's efforts to reinvigorate the nation's economy are showing...Tags: The New York Times, Viral Diseases and Infections, Human papillomavirus, Merck & Company Incorporated, Kennedy Airport
-
Merck, Glaxo reducen precio de vacuna contra cáncer cervical para países pobres
ReutersLONDRES (Reuters) - Las farmacéuticas Merck y GlaxoSmithKline redujeron el precio de las vacunas contra el cáncer de cuello de útero en un acuerdo que les permitirá venderlas a los países más pobres por menos de 5 dólares la dosis. El nuevo precio...Tags: Viral Diseases and Infections, HPV Vaccine, Merck & Company Incorporated
-
European shares dip from multi-year highs
ReutersPARIS, May 9 (Reuters) - European shares fell in early trade on Thursday, halting a sharp three-week rally to multi-year highs, with pharmaceutical stocks trimming recent lofty gains. GlaxoSmithKline and AstraZeneca were both down 0.5 percent. The sector...Tags: AstraZeneca Plc
-
Merck, GSK cut price of cervical cancer shots for poor countries
Reuters* Shots will cost less than $5 per dose through GAVI deal * Human papillomavirus causes most cervical cancers * Disease kills 275,000 women a year worldwide * Vaccine group deal aims to protect 30 million girls By Kate Kelland LONDON, May 9 (Reuters)...Tags: Chemical Industry, Vaccines, HPV Vaccine, Human papillomavirus, Merck & Company Incorporated
-
REUTERS SUMMIT-Drugmakers split as demands for open data mount
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Growing demands for transparency of clinical trial data * Wider disclosure by EU regulator angers drugmakers * GlaxoSmithKline sets up online system for data...Tags: Science and Technology, Chemical Industry, Merck & Company Incorporated, Politics, Denmark
-
JP Morgan, Greenhill advising GSK on sale of soft drinks brands
ReutersLONDON, May 2 (Reuters) - JP Morgan and Greenhill have been appointed to advise GlaxoSmithKline on the sale of its soft drinks brands Lucozade and Ribena, which analysts believe will fetch more than 1 billion pounds ($1.6 billion). A spokesman for...Tags: Bain Capital, LLC, Lion Capital Holdings, United Kingdom, Japan, Deutsche Bank AG
-
REUTERS SUMMIT-Drug industry CEOs plotting more carve-outs
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * New generation of CEOs more open to restructuring * Established drug products in focus at Pfizer, GSK, Sanofi * Bankers see divestments helping to unlock...Tags: Companies and Corporations, Corporate Officers, Abbott Laboratories, Bain Capital, LLC, Economy, Business and Finance
-
FACTBOX-Vaccine, drugs to fight new bird flu
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) May 6 (Reuters) - The U.N. World Health Organization and the U.S. Centers for Disease Control and Prevention are already working with samples of the new H7N9...Tags: Chemical Industry, Tamiflu (drug), Vaccines, Wildlife, AstraZeneca Plc
-
GSK to partner with venture capital firm for drug discovery
ReutersApril 22 (Reuters) - GlaxoSmithKline said on Monday it will partner with venture capitalists Avalon Ventures in a deal worth up to $495 million to fund as many as 10 drug-discovery startup companies over the next three years. GSK will provide financing...Tags: Avalon Ventures Limited, Startups
-
Athletes only too happy to be 'lab rats'
After discovering that a promising new drug caused multiple types of cancer in lab animals, the pharmaceutical company GlaxoSmithKline stopped developing the compound. But the failed experimental drug, called GW501516, is making a comeback in another...
Tags: Chemical Industry, Drug Use, Lawyers, Justice System, Bodybuilding
May 3, 2013
|Story| Reuters
May 2, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 8, 2013
|Story| Reuters
May 2, 2013
|Story| Reuters
May 7, 2013
|Story| Reuters
May 6, 2013
|Story| Reuters
Apr 22, 2013
|Story| Reuters
Apr 21, 2013
|Story| Chicago Tribune
Original site for GlaxoSmithKline PLC topic gallery.